Kimberly-Clark NA — Research, Selling and General Expense decreased by 3.7% to $259.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $262.00M to $259.00M. Over 3 years (FY 2022 to FY 2025), NA — Research, Selling and General Expense shows relatively stable performance with a 2.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to revenue suggests improved operational leverage, while an increase may indicate higher investment in innovation or administrative bloat.
Operating expenses related to research and development, sales force management, and general administrative support for a...
Standard operating expense category for large corporations, often compared against peers to measure administrative efficiency.
kmb_segment_na_research_selling_and_general_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $242.00M | $242.00M | $242.00M | $242.00M | $283.75M | $283.75M | $283.75M | $283.75M | $290.00M | $288.00M | $274.00M | $298.00M | $262.00M | $263.00M | $235.00M | $269.00M | $259.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +17.3% | +0.0% | +0.0% | +0.0% | +2.2% | -0.7% | -4.9% | +8.8% | -12.1% | +0.4% | -10.6% | +14.5% | -3.7% |
| YoY Change | — | — | — | — | +17.3% | +17.3% | +17.3% | +17.3% | +2.2% | +1.5% | -3.4% | +5.0% | -9.7% | -8.7% | -14.2% | -9.7% | -1.1% |